Please select the option that best describes you:
Can a second course of SRS be used to treat a brain met that initially responded to SRS and then progressed?
If progression is proven by imaging modality (MRI spectroscopy, perfusion and PET/CT), is there evidence for retreatment with a second course of SRS? If so, should a lower dose be used than would be typically used for the same size lesion?
Answer from: Radiation Oncologist at Community Practice
One should use caution in interpreting imaging as a definitive sign of progression, as sometimes radiation necrosis can mimic those findings. if asymptomatic, the patient can be considered for close observation with imaging and if symptomatic, one should consider a surgical option also.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
If there is compelling evidence for recurrence, there are a few small case series that demonstrate feasibility of repeat SRS. We recently presented our own series at ASTRO (http://www.redjournal.org/article/S0360-3016(14)01740-4/fulltext) demonstrating a 1y LRFS of 62.4% with 17% risk (4 pts) of gra...
Comments
Radiation Oncologist at Radiant Oncology
If it were biopsy proven vs surgically resected, w...
If it were biopsy proven vs surgically resected, w...
Answer from: Radiation Oncologist at Community Practice
I agree with caution in interpreting the results of PET and MRI spectroscopy. The specificity of PET, MRI, and MR spectroscopy vary from 50-80%. We have had a number of cases in which PET and MR spec were consistent with progressive disease and surgical pathology on the whole lesion showed radionecr...